Sleep Apnea, Obesity, and Disturbed Glucose Homeostasis: Epidemiologic Evidence, Biologic Insights, and Therapeutic Strategies.
Study Goal
The researchers aimed to explore the interconnectedness of obstructive sleep apnea (OSA), obesity, and disturbed glucose homeostasis, and how treating one condition (e.g., OSA with CPAP) may improve the others.
Results Summary
The study found that CPAP treatment for OSA appears to positively influence obesity and glucose homeostasis, suggesting interconnected therapeutic benefits among these conditions. The mechanisms include both direct and indirect weight-dependent pathways.
Population
Subjects with obesity, type 2 diabetes, and/or sleep disorders.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
weight loss induced by diet | increase | obstructive sleep apnea, obesity, and disturbed glucose homeostasis | subjects with obesity, type 2 diabetes, and/or sleep disorders | - | positively influence | #1 |
weight loss induced by bariatric surgery | increase | obstructive sleep apnea, obesity, and disturbed glucose homeostasis | subjects with obesity, type 2 diabetes, and/or sleep disorders | - | positively influence | #2 |
anti-obesity drugs | increase | obstructive sleep apnea, obesity, and disturbed glucose homeostasis | subjects with obesity, type 2 diabetes, and/or sleep disorders | - | positively influence | #3 |
antidiabetic drugs | increase | obstructive sleep apnea, obesity, and disturbed glucose homeostasis | subjects with obesity, type 2 diabetes, and/or sleep disorders | - | positively influence | #4 |
continuous positive airway pressure (CPAP) | increase | obstructive sleep apnea, obesity, and disturbed glucose homeostasis | subjects with obesity, type 2 diabetes, and/or sleep disorders | - | positively influence | #5 |
PURPOSE OF REVIEW: Obstructive sleep apnea (OSA), obesity, and disturbed glucose homeostasis are usually considered distinct clinical condition, although they are tightly related to each other. The aim of our manuscript is to provide an overview of the current evidence on OSA, obesity, and disturbed glucose homeostasis providing epidemiologic evidence, biological insights, and therapeutic strategies. RECENT FINDINGS: The mechanisms hypothesized to be involved in this complex interplay are the following: (1) "direct weight-dependent" mechanisms, according to which fat excess compromises respiratory mechanics, and (2) "indirect weight-dependent" mechanisms such as hyperglycemia, insulin resistance and secondary hyperinsulinemia, leptin resistance and other hormonal dysregulations frequently found in subjects with obesity, type 2 diabetes, and/or sleep disorders. Moreover, the treatment of each of these clinical conditions, through weight loss induced by diet or bariatric surgery, the use of anti-obesity or antidiabetic drugs, and continuous positive airway pressure (CPAP), seems to positively influence the others. These recent data suggest not only that there are multiple connections among these diseases but also that treating one of them may result in an improvement of the others.